May 29, 2009 | Drug Store News
Verus Pharmaceuticals files lawsuit against AstraZeneca
SAN DIEGO A pharmaceutical company focused on drugs for children has filed a lawsuit against Anglo-Swedish drug maker AstraZeneca.
CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results For...
CyDex Pharmaceuticals, Inc. announced the presentation of Phase 2 clinical trial results of its novel, proprietary Captisol-Enabled budesonide/azelastine nasal spray for seasonal allergic rhinitis .
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
EWING, N.J., March 13, 2009 /PRNewswire-FirstCall/ DOR BioPharma, Inc. announced today that it has appointed Brian L. Hamilton, MD, PhD, as Senior Vice President and Chief Medical Officer.
CyDex Pharmaceuticals Announces Successful Completion Of Phase II...
CyDex Pharmaceuticals, Inc. announced that it has successfully completed an early proof-of-concept phase II clinical trial of its Captisol-Enabled budesonide/azelastine nasal spray for seasonal allergic ...